r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

MF

Margaret M. FitzPatrick

Insider · Director · ANTX

Margaret M. FitzPatrick files insider transactions with the SEC as a director of AN2 Therapeutics (ANTX). We hold 1 disclosed purchase or sale filed since 22 July 2021, 1 of them in the last 90 days.

  • Files forANTX
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure2 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 5 May 2022 — 1 September 2026Director · AN2 Therapeutics (ANTX)21 Form 4 lines · source: SEC Form 4
  • Filed 21 July 2021 — 9 September 2025Director · Vistagen Therapeutics (VTGN)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

26 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.